These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23837573)

  • 21. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
    Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
    Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of antimycobacterial activity of a sulphonamide derivative.
    Agertt VA; Marques LL; Bonez PC; Dalmolin TV; Manzoni de Oliveira GN; de Campos MM
    Tuberculosis (Edinb); 2013 May; 93(3):318-21. PubMed ID: 23474303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
    Sulthana MT; Alagarsamy V; Chitra K
    Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
    Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
    Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.
    Venugopala KN; Tratrat C; Pillay M; Mahomoodally FM; Bhandary S; Chopra D; Morsy MA; Haroun M; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Venugopala R; Chandrashekharappa S; Alwassil OI; Odhav B
    Antibiotics (Basel); 2019 Dec; 8(4):. PubMed ID: 31816928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.
    Das R; Mehta DK
    Drug Res (Stuttg); 2021 Jan; 71(1):26-35. PubMed ID: 33027823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity.
    Pflégr V; Horváth L; Stolaříková J; Pál A; Korduláková J; Bősze S; Vinšová J; Krátký M
    Eur J Med Chem; 2021 Nov; 223():113668. PubMed ID: 34198149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
    Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
    Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.
    Lupien A; Foo CS; Savina S; Vocat A; Piton J; Monakhova N; Benjak A; Lamprecht DA; Steyn AJC; Pethe K; Makarov VA; Cole ST
    PLoS Pathog; 2020 Jan; 16(1):e1008270. PubMed ID: 31971990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and biological evaluation of
    Zhang NN; Liu ZY; Liang J; Tang YX; Qian L; Gao YM; Zhang TY; Yan M
    Medchemcomm; 2018 Aug; 9(8):1293-1304. PubMed ID: 30151083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Anti-mycobacterial Activity of Three Medicinal Plants of Lamiaceae Family.
    Kazemian H; Heidari H; Yamchi JK; Zandi H; Taji A; Yazdani F; Hamzehloo G; Ghanavati R; Rahdar HA; Feizabadi MM
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):240-245. PubMed ID: 29952265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.
    Venugopala KN; Al-Shar'i NA; Dahabiyeh LA; Hourani W; Deb PK; Pillay M; Abu-Irmaileh B; Bustanji Y; Chandrashekharappa S; Tratrat C; Attimarad M; Nair AB; Sreeharsha N; Shinu P; Haroun M; Kandeel M; Balgoname AA; Venugopala R; Morsy MA
    Antibiotics (Basel); 2022 Jun; 11(7):. PubMed ID: 35884084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of indolopyridone hybrids as new antituberculosis agents.
    Rather MA; Rasool F; Bhat ZS; Dar HU; Maqbool M; Amin S; Yousuf SK; Ahmad Z
    Microb Pathog; 2017 Dec; 113():330-334. PubMed ID: 29079215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
    Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
    Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
    Sriram D; Aubry A; Yogeeswari P; Fisher LM
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
    Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
    Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
    Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.